Your SlideShare is downloading. ×

Dna of biopreneur

593

Published on

Waht

Waht

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
593
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. DNA of Biopreneur
    A.S.Rao
    Adviser-Innovation Clusters,FMC
    indiainvents@hotmail.com
    http://www.indiainvents.blogspot.com/
  • 2. Molecule millionaires
    Scientist turned promoter: Dr Anji Reddy (DPR), Ketan R Patel(Troikka), Krishna Ella (Bharat Biotech), Ramanbhai Patel(Cadia),
    Biopreneurs: Ranbir Singh & Gurbax Singh (Ranbaxy), UN Mehta (Torrent), Varaprasad Reddy (Shanta Biotech), Raghavendrarao (Orchid)
  • 3. Signature of success
    Master the virtuous cycle of knowledge management.
    Identify business opportunity, decipher key factors, relate to technology, acquire technology and raise the stock of Firm Specific Knowledge.
    Learn to network with knowledge partners and knowledge workers.
    Lead cluster formation as network orchestrator
  • 4. Knowledge cycle
  • 5. Opportunities
    Patents not enforced in India
    Drugs going off the patents
    Affordable health care
    100 global technologies shortlisted by knowledge partner Sky Quest.
  • 6. Patents not enforced in India
    http://www.globalinnovationcommons.org
    Buruli Ulcer, Dengue Fever, Dracunculiasis(Guinea Worm Disease), Leprosy, Lymphatic Filariasis, Malaria, Sickle Cell Anemia, Snake Bite, Spider Bite
  • 7. Going off the patent
     22 drugs will go off-patent in India by 2015-Rituxan, an anti-neoplasticmAbs from Roche; Lantus, an antidiabetics from Sanofiaventis; and Neulasta, an immunostimulants from Amgen; have record sales of $5.6 billion, $4.3 billion and $3.4 billion respectively. Similarly, Epogen from Amgen, Avonex from Biogen Idec, Eprex from Johnson & Johnson and Rebif from Merck, which reported sales of over $2 billion in 2009, will lose patents by 2013.
  • 8. Affordable health care
    Service innovations: Eye care, Heart surgery, Tele medicine, remote monitoring of patients,
    Reverse innovations: from Innovators/ start-ups –Mosquito traps, infant warmers
    Non-profit design centers:
    http://www.d-rev.org/index.html
  • 9. Services needed
    Technology search, access, acquisition, negotiation
    Business plan
    Regulatory approvals
  • 10. Biopreneur program

×